SCHEMBL577313

SCHEMBL577313

Cc1c(-c2nc(C(C)C)cs2)[c]nc2ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR4 P51679 1/20 0.39
CSNK2A2 P19784 1/20 0.32
CSNK2B P67870 1/20 0.32
CSNK2A1 P68400 1/20 0.32
CSNK2A3 Q8NEV1 1/20 0.32
TYK2 P29597 1/20 0.31
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30
TP53 P04637 1/20 0.30
CYP3A4 P08684 1/20 0.30
HPGD P15428 1/20 0.30
MAPK1 P28482 1/20 0.30
KMT2A Q03164 1/20 0.30
HSD17B10 Q99714 1/20 0.30
CTSK P43235 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
GRM1 Q13255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL576844 0.86 CCR4 (0.38) CCR4CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL577569 0.84 POLB (0.41) CCR4CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL577312 0.82 CCR4 (0.39) CCR4CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL578167 0.78 APLNR (0.38) CCR4TYK2KDM4EALDH1A1HPGD
SCHEMBL576843 0.78 CCR4 (0.38) CCR4CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL577280 0.77 TYK2 (0.32) TYK2MEN1KMT2A
SCHEMBL577568 0.76 CCR4 (0.36) CCR4CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL577452 0.74 TP53 (0.40) CCR4TYK2KDM4EALDH1A1TP53
SCHEMBL577645 0.74 CCR4 (0.38) CCR4CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL578166 0.73 CCR4 (0.34) CCR4TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2461811-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV IDENIX Pharmaceuticals, Inc. (US) 2012-06-13 EP disclosed
EP-2417134-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX Pharmaceuticals, Inc. (US) 2012-02-15 EP disclosed
WO-2011017389-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV IDENIX PHARMACEUTICALS, INC. (US) 2011-02-10 WO disclosed
WO-2010118078-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX PHARMACEUTICALS, INC. (US) 2010-10-14 WO disclosed